(Press-News.org) The International Society for Stem Cell Research (ISSCR) today announced that registration and abstract submission are open for the ISSCR International Symposium: 20 Years of iPSC Discovery: A Celebration and Vision for the Future, co-sponsored by the Japanese Society for Regenerative Medicine. The symposium will take place 20–22 October 2026 in Kyoto, Japan.
Developed in partnership with the Center for iPS Cell Research and Application (CiRA) at Kyoto University, the scientific program is chaired by Shinya Yamanaka, recipient of the 2012 Nobel Prize in Physiology or Medicine for the discovery of induced pluripotent stem cells (iPSCs), an honor he shared with the late Sir John Gurdon.
“The ISSCR is honored to convene the community in Kyoto for this historic moment,” said Hideyuki Okano, ISSCR President. “Throughout the last 20 years, iPSC technologies have continued to open unexpected scientific frontiers and move steadily toward clinical impact. Gathering in Kyoto – the birthplace of iPSCs – gives us a unique opportunity to celebrate the journey and set an ambitious vision for the next two decades.”
The discovery of iPSCs revolutionized biology by showing that mature cells can be reprogrammed to an embryonic-like, pluripotent state, allowing the creation of patient-specific cells capable of differentiating into nearly any cell type. This breakthrough transformed disease modeling, drug discovery, and regenerative medicine, opening new frontiers for cell therapy development. Today, iPSC-derived models and organoids are accelerating insights into diseases such as Parkinson’s, Alzheimer’s, cardiovascular, and rare genetic disorders - driving innovation in understanding disease mechanisms and advancing therapeutic discovery.
Program Leadership and Organizers
Chaired by Shinya Yamanaka, CiRA, Kyoto University & CiRA Foundation, Japan; Gladstone Institutes, USA, the symposium is co-organized by Jun Takahashi, CiRA, Kyoto University, Japan, Takanori Takebe, Cincinnati Children’s Hospital Medical Center, USA, Christine Mummery, Leiden University Medical Center, Netherlands, and Emily Titus, Notch Therapeutics, Canada.
Featured Sessions & Speakers
Opening Keynote
Shinya Yamanaka, CiRA, Kyoto University & CiRA Foundation, Japan; Gladstone Institutes, USA
Janet Rossant, Senior Scientist Emeritus, The Hospital for Sick Children; Editor-in-Chief, Stem Cell Reports, Canada
George Q. Daley, Harvard Medical School, USA
Molecular and Cellular Mechanisms in iPSC Biology
Yasuhiro Takashima, CiRA, Kyoto University, Japan
Nissim Benvenisty, The Hebrew University, Israel
Maike Sander, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Germany
iPSC Differentiation and Maturation
Karl R. Koehler, Boston Children’s Hospital & Harvard Medical School, USA
Elizabeth Ng, Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW Melbourne & Murdoch Children’s Research Institute, Australia
Olivier Pourquié, Harvard Medical School, USA
Disease Modeling with iPS Cells
Bruce R. Conklin, Gladstone Institutes, USA
Silvia Velasco, Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW Melbourne & Murdoch Children’s Research Institute, Australia
Mingxia Gu, University of California, Los Angeles, USA
Clinical Applications of iPS Cells
Masayo Takahashi, Vision Care Inc.; Kobe City Eye Hospital; Ritsumeikan University, Japan
Bob Valamehr, Fate Therapeutics, USA
Xiaokui Zhang, Aspen Neuroscience, Inc., USA
Bioengineering Approaches in iPSC Modeling
Orly Reiner, Weizmann Institute of Science, Israel
Philipp Wörsdörfer, University of Würzburg, Germany
Harsha D. Devalla, Amsterdam University Medical Center, Netherlands
Enabling Technologies for the Next Breakthrough
Azadeh Golipour, GC Therapeutics, USA
Yoshiyuki Sankai, University of Tsukuba; President & CEO, CYBERDYNE Inc.; Program Director, SIP, Cabinet Office, Government of Japan
Ruwanthi Gunawardane, Allen Institute for Cell Science, USA
Muzlifah Haniffa, Wellcome Sanger Institute, UK
Submit an abstract before 29 July 2026 at 11:59 PM EDT and register before then for the best rates.
To commemorate the anniversary and highlight new advances enabled by iPSC technology, Stem Cell Reports, the open-access, peer-reviewed journal of the ISSCR, will publish a special issue aligned with the symposium.
About ISSCR
With nearly 5,000 members from more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.
END
Registration and Abstract Submission Open for “20 Years of iPSC Discovery: A Celebration and Vision for the Future,” 20-22 October 2026, Kyoto, Japan
International Symposium chaired by Nobel Laureate Shinya Yamanaka to honor the past and chart the future of induced pluripotent stem cell (iPSC) science
2025-11-04
ELSE PRESS RELEASES FROM THIS DATE:
Half-billion-year-old parasite still threatens shellfish
2025-11-04
A new study has unexpectedly discovered that a common parasite of modern oysters actually started infecting bivalves hundreds of millions of years before the dinosaurs went extinct.
The research, published in iScience, used high-resolution 3D scans to look inside 480-million-year-old shells from a Moroccan site known for its exceptionally well-preserved sea life. The scans revealed a series of distinctive patterns etched both on the surface of the fossils and hidden inside them.
“The marks weren’t random scratches,” said Karma Nanglu, a UC Riverside paleobiologist who led the research. “We saw seven or eight of these perfect question mark shapes on each ...
Engineering a clearer view of bone healing
2025-11-04
Healing a broken bone can take months, and knowing whether recovery is on track often takes just as long. Doctors typically rely on periodic X-rays, capturing two-dimensional images to see how the bone is growing back together. Patients return for follow-up scans every few weeks or months, repeating the cycle until the bone shows signs of complete healing.
Healing of shin bone (tibia) fractures, in particular, slows or stalls up to 25% of the time. Factors such as age or underlying health conditions like diabetes can influence the speed of fracture healing. Delayed or incomplete ...
Detecting heart issues in breast cancer survivors
2025-11-04
As breast cancer survival rates continue to climb — 4.3 million women in the U.S. are currently living with a history of the disease and in the next 10 years that number is expected to rise by another million — heart health has become an increasingly important part of survivorship care.
Certain breast cancer therapies, while lifesaving, can also place stress on the heart, raising important questions about who might benefit from closer monitoring.
But does every breast cancer survivor need ...
Moffitt study finds promising first evidence of targeted therapy for NRAS-mutant melanoma
2025-11-04
Moffitt Cancer Center researchers report the first clinical activity of a RAS inhibitor in patients with NRAS-mutant melanoma.
The investigational drug daraxonrasib (RMC-6236) and its preclinical counterpart RMC-7977 bind active RAS proteins (NRAS, HRAS, KRAS) and block downstream signaling that drives tumor growth, survival and immune escape.
In laboratory models, treatment led to increased infiltration of activated T cells, reduction of suppressive immune cells and tumor eradication only when the immune ...
Lay intuition as effective at jailbreaking AI chatbots as technical methods
2025-11-04
UNIVERSITY PARK, Pa. — It doesn’t take technical expertise to work around the built-in guardrails of artificial intelligence (AI) chatbots like ChatGPT and Gemini, which are intended to ensure that the chatbots operate within a set of legal and ethical boundaries and do not discriminate against people of a certain age, race or gender. A single, intuitive question can trigger the same biased response from an AI model as advanced technical inquiries, according to a team led by researchers at Penn State.
“A lot of research on AI bias has relied on sophisticated ...
USC researchers use AI to uncover genetic blueprint of the brain’s largest communication bridge
2025-11-04
For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has mapped the genetic architecture of a crucial part of the human brain known as the corpus callosum—the thick band of nerve fibers that connects the brain’s left and right hemispheres. The findings open new pathways for discoveries about mental illness, neurological disorders and other diseases related to defects in this part of the brain.
The corpus callosum is critical for nearly everything the brain does, from coordinating ...
Tiny swarms, big impact: Researchers engineering adaptive magnetic systems for medicine, energy and environment
2025-11-04
Rice University is partnering with researchers at the University of Washington, Columbia University and Louisiana State University on a $2 million award from the National Science Foundation to revolutionize how materials and microrobots can be designed, controlled and applied in real-world environments.
Funded through NSF’s Designing Materials to Revolutionize and Engineer our Future (DMREF) program, the four-year project — Adaptive and Responsive Magnetic Swarms (ARMS) — aims to create microscopic robotic swarms that move and think collectively, much like schools of fish or flocks of birds.
Led by principal investigator Zach ...
MSU study: How can AI personas be used to detect human deception?
2025-11-04
EAST LANSING, Mich. – Can an AI persona detect when a human is lying – and should we trust it if it can? Artificial intelligence, or AI, has had many recent advances and continues t evolve in scope and capability. A new Michigan State University–led study is diving deeper into how well AI can understand humans by using it to detect human deception.
In the study, published in the Journal of Communication, researchers from MSU and the University of Oklahoma conducted 12 experiments with over 19,000 AI participants to examine how well AI personas were ...
Slowed by sound: A mouse model of Parkinson’s Disease shows noise affects movement
2025-11-04
In the development of Parkinson’s disease, it may not be a good idea to turn the amp to 11. High-volume noise exposure produced motor deficits in a mouse model of early-stage Parkinson’s disease, and established a link between the auditory processing and movement areas of the brain, according to a study published November 4th in the open-access journal PLOS Biology by Pei Zhang from the Huazhong University of Science and Technology in Wuhan, China, and colleagues.
The environment can play an important role in the development of Parkinson’s disease, but how sound volume in particular might impact the severity of symptoms was unknown. To understand how ...
Demographic shifts could boost drug-resistant infections across Europe
2025-11-04
The rates of bloodstream infections caused by drug-resistant bacteria will increase substantially across Europe in the next five years, driven largely by aging populations, according to a new paper published November 4th in the open-access journal PLOS Medicine by Gwenan Knight of the London School of Hygiene and Tropical Medicine, UK, and colleagues.
Antimicrobial resistance (AMR) is a global public health crisis. To effectively target interventions and track progress toward international goals, accurately estimating how the AMR burden will change over time is necessary.
In ...
LAST 30 PRESS RELEASES:
Study finds moral costs in over-pricing for essentials
Australian scientists uncover secrets of yellow fever
Researchers develop high-performance biochar for efficient carbon dioxide capture
Biodegradable cesium nanosalts activate anti-tumor immunity via inducing pyroptosis and intervening in metabolism
Can bamboo help solve the plastic pollution crisis?
Voting behaviour in elections strongly linked to future risk of death
Significant variations in survival times of early onset dementia by clinical subtype
Research finds higher rare risk of heart complications in children after COVID-19 infection than after vaccination
Oxford researchers develop ‘brain-free’ robots that move in sync, powered entirely by air
The science behind people who never forget a face
Study paints detailed picture of forest canopy damage caused by ‘heat dome’
New effort launched to support earlier diagnosis, treatment of aortic stenosis
Registration and Abstract Submission Open for “20 Years of iPSC Discovery: A Celebration and Vision for the Future,” 20-22 October 2026, Kyoto, Japan
Half-billion-year-old parasite still threatens shellfish
Engineering a clearer view of bone healing
Detecting heart issues in breast cancer survivors
Moffitt study finds promising first evidence of targeted therapy for NRAS-mutant melanoma
Lay intuition as effective at jailbreaking AI chatbots as technical methods
USC researchers use AI to uncover genetic blueprint of the brain’s largest communication bridge
Tiny swarms, big impact: Researchers engineering adaptive magnetic systems for medicine, energy and environment
MSU study: How can AI personas be used to detect human deception?
Slowed by sound: A mouse model of Parkinson’s Disease shows noise affects movement
Demographic shifts could boost drug-resistant infections across Europe
Insight into how sugars regulate the inflammatory disease process
PKU scientists uncover climate impacts and future trends of hailstorms in China
Computer model mimics human audiovisual perception
AC instead of DC: A game-changer for VR headsets and near-eye displays
Prevention of cardiovascular disease events and deaths among black adults via systolic blood pressure equity
Facility-based uptake of colorectal cancer screening in 45- to 49-year-olds after US guideline changes
Scientists uncover hidden nuclear droplets that link multiple leukemias and reveal a new therapeutic target
[Press-News.org] Registration and Abstract Submission Open for “20 Years of iPSC Discovery: A Celebration and Vision for the Future,” 20-22 October 2026, Kyoto, JapanInternational Symposium chaired by Nobel Laureate Shinya Yamanaka to honor the past and chart the future of induced pluripotent stem cell (iPSC) science